aap Implantate AG

Earnings Release • Jan 17, 2006

News Details

Corporate | 17 January 2006 07:40

aap: Preliminary Sales Figures for Q4 (+22%) and FY 2005 (+15%)

Corporate-news transmitted by DGAP. The issuer is solely responsible for the content of this announcement. —————————————————————————— aap: Preliminary Sales Figures for Q4 (+22%) and FY 2005 (+15%) aap Implantate AG, a German medical technology company specialized in healing fractures, joint replacement, bone cements and biomaterials, reports preliminary sales of EUR 3.6 million in the fourth quarter of 2005 – a 22% year-on-year increase (previous year: EUR 3.0 million). In the full financial year 2005 the Group’s preliminary sales totaled EUR 13.3 million and were therefore 15% up on the previous year’s EUR 11.5 million. ADC and Osartis, companies acquired as of October 1, 2005 and since fully consolidated, posted combined sales of around EUR 0.2 million to the total revenues. Without these contributions Group’s organic growth would be 13.2%. Sales growth was mainly in biomaterials and bone cements. aap anticipates further significant sales growth in the year ahead. aap Implantate AG’s full financial statements for 2005 will be published on March 31, 2006. End of announcement (c)DGAP 17.01.2006 —————————————————————————— WKN: 506660; ISIN: DE0005066609; Index: Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart